BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21616045)

  • 1. Pharmacogenetic mechanisms underlying unanticipated drug responses.
    Carlquist JF; Anderson JL
    Discov Med; 2011 May; 11(60):469-78. PubMed ID: 21616045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics in biological perspective.
    Kalow W
    Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide identification of structural variants in genes encoding drug targets: possible implications for individualized drug therapy.
    Rasmussen HB; Dahmcke CM
    Pharmacogenet Genomics; 2012 Jul; 22(7):471-83. PubMed ID: 22466257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
    Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
    Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic differences in drug metabolism and response.
    Vetticaden SJ
    Methods Find Exp Clin Pharmacol; 1988 Aug; 10(8):531-6. PubMed ID: 3067018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacogenetics.
    Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
    Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic variations affect drug safety and efficacy].
    Harmsze AM; Deneer VH; Maitland-van der Zee AH; de Boer A; Klungel OH
    Ned Tijdschr Geneeskd; 2010; 154():A1503. PubMed ID: 20699026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics/genomics and personalized medicine.
    Sadée W; Dai Z
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenomics and interindividual differences in drug response.
    Ivanov M; Kacevska M; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2012 Dec; 92(6):727-36. PubMed ID: 23093317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology.
    Csoka AB; Szyf M
    Med Hypotheses; 2009 Nov; 73(5):770-80. PubMed ID: 19501473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics in HIV therapy.
    Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
    AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein therapeutics: new applications for pharmacogenetics.
    Krejsa C; Rogge M; Sadee W
    Nat Rev Drug Discov; 2006 Jun; 5(6):507-21. PubMed ID: 16763661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNVs of human genes and their implication in pharmacogenetics.
    Johansson I; Ingelman-Sundberg M
    Cytogenet Genome Res; 2008; 123(1-4):195-204. PubMed ID: 19287156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.